What sector is CDIOW in?

Healthcare, in the Diagnostics industry.

NASDAQ · CDIOWHealthcareDiagnostics

Cardio Diagnostics Holdings Inc. Warrant (CDIOW)

$0.01000.00%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$0.01▼ 50.50% in range

Sep 29, 2025Low $0.01 · High $0.05Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Cardio Diagnostics Holdings Inc. Warrant closed at $0.01 on Sep 28, unchanged, within 0.0% of its lowest close since Oct 26. Volume of 15.2K shares was 1.34× its 20-day average (above normal).

Split-adjusted performance: -40.5% over one month, -49.5% over six months.

In the quarter ended Jun 30, 2026, revenue was $5.36K, down 28.3% from a year earlier, with a net margin of -28012.5%.

Short interest was 26.3K shares at the Sep 15 settlement (7.9 days to cover).

Market cap—

Revenue · quarter$5.4K−28.3% YoY

Diluted EPS$-0.51—

P/E · TTM—

Net margin-28,012.5%Gross 100.0%

Dividend yieldNone

Range since Oct 260.01 – 0.05−81.1% from high

Volume15.2K1.34× 20-day avg

Volatility · 60d270.3%Annualised

Short % of float—7.9 days to cover

Net cash$5.6MCash $5.6M

Next earnings—Not scheduled

Split-adjusted performance

1W −3.8%1M −40.5%3M −45.1%6M −49.5%YTD −61.4%1Y —3Y −78.9%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Diagnostics

Percentile among 15 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −0.9%, revenue growth −0.1%, net margin −26.0%, P/E 36.6×.

Short interest

Details →

Shares short26.3K−0.9% vs prior

Days to cover7.9Settled Sep 15

% of float—

Short vol. 10d—of daily volume

News about Cardio Diagnostics Holdings Inc. Warrant

All news →

No recent articles focused on Cardio Diagnostics Holdings Inc. Warrant.

Quick answers

What does Cardio Diagnostics Holdings Inc. Warrant do?: Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks.
What sector is CDIOW in?: Healthcare, in the Diagnostics industry.

About Cardio Diagnostics Holdings Inc. Warrant

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

HQ: Chicago, IL17 employeesListed Oct 26, 2022cdio.ai

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology